Published in Vaccine Weekly, June 22nd, 2005
Rincon Pharmaceuticals is a San Diego, California-based biopharmaceuticals company using eukaryotic algae to produce human therapeutic proteins, especially monoclonal antibodies. Rincon intends to use its proprietary technology to develop and manufacture both partnered and proprietary protein-based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly